Base excess (BE) was introduced by Siggaard-Andersen in 1960 as an answer to the forty-year-long quest for a reliable, stand-alone marker of metabolic acidosis/alkalosis, independent from co-existing respiratory derangements, and able to quantify the severity of the disorder [1]. Previously, several parameters had been examined. The first was actual bicarbonate (HCO3−) [2], which was quickly discarded due to its known dependency on the partial pressure of CO2 (PCO2). To eliminate the respiratory component, standard bicarbonate (HCO3−(st)) was introduced, representing the plasma bicarbonate concentration after equilibration at a PCO2 of 40 mmHg [3]. Although this was certainly a step forward, HCO3−(st) does not take into account the buffer effect of weak non-carbonic acids, i.e. proteins, which normally contribute to buffering with 14–16 negative charges (A−) per liter. Indeed, when a strong acid is added to blood, both HCO3− and A− concentrations will be reduced. In an open system, which is the case of a subject properly regulating PCO2 through breathing, carbonic buffers have a predominant role (about 75–80%), however, non-carbonic buffers cannot be disregarded completely. Therefore, the difference between HCO3−(st) and the ideal, “normal” bicarbonate value, slightly underestimates the acid/base added to the system (e.g. the addition of 10 mmol/L of a strong acid to blood with HCO3− of 24 mmol/L could result in an HCO3−(st) of 16 mmol/L, instead of 24–10 = 14 mmol/L). To overcome this problem, Singer and Hastings introduced the buffer base (BB), the sum of all buffer anions [4].
The BB considers the non-carbonic buffers and is theoretically CO2-independent. Unfortunately, a physiologic inter-subject variability due to different non-carbonic buffer concentrations was noticed [5]. To overcome this limitation, Siggaard-Andersen introduced the base excess (BE), i.e. the “excess” (either positive or negative) of the actual BB as compared to the Normal BB (NBB).
The NBB is the BB experimentally obtained through equilibration and titration procedures aimed to achieve normal conditions of pH of 7.40 and PCO2 of 40 mmHg. Consequently, BE is the amount of acid/base (mmol/L) that must be added to the blood sample to reach pH of 7.40 in standardized conditions (PCO2 40 mmHg, 37 °C) [6].
As direct titration is obviously impossible in a clinical scenario, nomograms and formulae were developed to estimate BE. The most common equation, which is still in use, is the following:
where 24.8 and 7.40 are the reference, ideal HCO3− (mmol/L) and pH values, and β is the buffer power (mmol/L) of non-carbonic weak acids [7, 8], which can either be a constant value (16.2 mmol/L) or computed as a function of hemoglobin concentration (assuming a constant protein concentration of 70 g/L) [9, 10]. The β value, multiplied by the variation in pH, provides an estimate of the change in weak negative charges due to non-carbonic buffers. Of note, from a clinical point of view, the variation in β value has a minor impact on the BE computation.
Generally, BE range between − 2 and + 2 mmol/L is considered normal. Clinical examples of abnormal BE values are reported in Fig. 1.
Base excess can either be expressed for whole blood—BE(B), which does not consider the interaction of blood with the interstitial fluid, or for the entire extracellular fluid—BE(ecf), also called standard BE (SBE). The SBE calculation uses the same equation but considers a lower concentration of hemoglobin (either 1/3 of the actually measured hemoglobin or a constant concentration) for the estimation of β. Despite this conceptual difference, even in the presence of extreme anemia or polycythemia, it is hard to imagine conditions in which BE(B) and BE(ecf) would lead to markedly different results, diagnoses and therapeutic interventions. Nevertheless, SBE is generally considered a better and more reliable parameter and should therefore be preferred in clinical practice [11, 12].
Not all that glitters is gold
We have highlighted the usefulness and strengths of SBE, but some limitations exist and should be kept in mind in our daily practice. First, while SBE is a valuable quantitative estimate of metabolic acid–base derangements, it does not provide any information about the underlying mechanisms. Indeed, to identify the underlying pathologic mechanism we have to evaluate other variables, such as electrolytes, lactate, proteins, phosphates and clinical history. Second, SBE is a composite marker, i.e. several components contribute to its final value (e.g. chloride, lactate, albumin, ketoacids) [13, 14]. Therefore, different components could operate in opposite directions, potentially cancelling out each other and making the interpretation of the isolated SBE value very difficult. Let us provide an example. A patient could have hyperchloremia, therefore an increase in strong anions, together with hypoalbuminemia, leading to a reduction in weak negative charges. If the reduction in negative charges due to hypoalbuminemia is equal to the increase in chloride, HCO3− concentration will be normal. The patient could therefore have normal acid–base parameters (pH 7.40, pCO2 40 mmHg, HCO3− 24 mmol/L) yielding a perfectly normal SBE of 0 mmol/L. Is the value of SBE in this context wrong? No, it is not. The SBE correctly states that we do not need to add strong acids/bases to the sample to reach a pH of 7.40 with a PCO2 of 40 mmHg. We are already there! However, two pathologic processes (with opposite sign) are present and would be missed if SBE was assessed on its own. Gamblegrams [15] of other examples of multiple acid–base derangements leading to normal SBE values are summarized in Fig. 1.
SBE is a useful parameter to assist in the diagnosis of metabolic acid–base disorders and to assess the metabolic displacement quantitatively. It is a calculated value, that relies on several measured variables (pH, PCO2, hemoglobin concentration) and assumes normal plasma proteins. Importantly, SBE by itself does not provide information about the underlying condition and could be perfectly normal in the case of multiple conditions acting in opposite directions. Therefore, while an abnormal SBE is a reliable marker of an active metabolic issue, a normal SBE is not enough to exclude it. For this reason, SBE cannot be considered a stand-alone parameter. Indeed, it is fundamental to integrate its values with other information to identify complex acid–base disorders.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Declarations
Conflicts of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter discussed in this manuscript.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Severinghaus JW, Astrup PB. History of blood gas analysis. II. pH and acid-base balance measurements. J Clin Monit. 1985;1:259–277. doi: 10.1007/bf02832819. [DOI] [PubMed] [Google Scholar]
- 2.Van Slyke DD, Cullen GE. Studies of acidosis. I. The bicarbonate concentration of the blood plasma; its significance and its determination as a measure of acidosis. J Biol Chem. 1917;30:289. doi: 10.1016/S0021-9258(18)86738-2. [DOI] [Google Scholar]
- 3.Jorgensen K, Astrup P. Standard bicarbonate, its clinical significance, and a new method for its determination. Scand J Clin Lab Invest. 1957;9:122–132. doi: 10.3109/00365515709101210. [DOI] [PubMed] [Google Scholar]
- 4.Singer RB, Hastings AB. An improved clinical method for the estimation of disturbances of the acid-base balance of human blood. Medicine. 1948;27:223–242. doi: 10.1097/00005792-194805000-00003. [DOI] [PubMed] [Google Scholar]
- 5.Astrup P, Jorgensen K, Siggaard-Andersen O, Engel K. The acid-base metabolism. A new approach. Lancet (London, England) 1960;1:1035–1039. doi: 10.1016/s0140-6736(60)90930-2. [DOI] [PubMed] [Google Scholar]
- 6.Siggaard-Andersen O (1974) The acid-base status of the blood. Williams & Wilkins, Munksgaard, Baltimore, Copenhagen
- 7.Van Slyke DD. On the measurement of buffer values and on the relationship of buffer value to the dissociation constant of the buffer and the concentration and reaction of the buffer solution. J Biol Chem. 1922;52:525–570. doi: 10.1016/S0021-9258(18)85845-8. [DOI] [Google Scholar]
- 8.Langer T, Brusatori S, Carlesso E, Zadek F, Brambilla P, Ferraris Fusarini C, Duska F, Caironi P, Gattinoni L, Fasano M, Lualdi M, Alberio T, Zanella A, Pesenti A, Grasselli G, (2021) Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: an in vitro study. J Appl Physiol (Bethesda, Md : 1985) 131:464–473. 10.1152/japplphysiol.00787.2020 [DOI] [PubMed]
- 9.Siggaard-Andersen O. The van Slyke equation. Scand J Clin Lab Investig Suppl. 1977;146:15–20. doi: 10.3109/00365517709098927. [DOI] [PubMed] [Google Scholar]
- 10.Lang W, Zander R. The accuracy of calculated base excess in blood. Clin Chem Lab Med. 2002;40:404–410. doi: 10.1515/cclm.2002.065. [DOI] [PubMed] [Google Scholar]
- 11.Kofstad J. Base excess: a historical review-has the calculation of base excess been more standardised the last 20 years? Clin Chim Acta Int J Clin Chem. 2001;307:193–195. doi: 10.1016/s0009-8981(01)00427-2. [DOI] [PubMed] [Google Scholar]
- 12.Morgan TJ, Clark C, Endre ZH. Accuracy of base excess–an in vitro evaluation of the Van Slyke equation. Crit Care Med. 2000;28:2932–2936. doi: 10.1097/00003246-200008000-00041. [DOI] [PubMed] [Google Scholar]
- 13.Fencl V, Leith DE. Stewart's quantitative acid-base chemistry: applications in biology and medicine. Respir Physiol. 1993;91:1–16. doi: 10.1016/0034-5687(93)90085-o. [DOI] [PubMed] [Google Scholar]
- 14.Morgan TJ. Partitioning standard base excess: a new approach. J Clin Monit Comput. 2011;25:349–352. doi: 10.1007/s10877-011-9324-y. [DOI] [PubMed] [Google Scholar]
- 15.Gamble JL, Ross GS, Tisdall FF. The metabolis of fixed base during fasting. J Biol Chem. 1923;57:633–695. doi: 10.1016/S0021-9258(18)85480-1. [DOI] [Google Scholar]